Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC149

Mepólísúmab

  • Status:
    Veitt
  • Application date:
    14.3.2016
  • Application published:
    15.4.2016
  • Grant published:
    15.4.2018
  • Max expiry date:
    6.6.2031
  • Medicine name:
    Nucala - mepolizumab
  • Medicine for children:
    Yes

Timeline

Today
14.3.2016Application
15.4.2016Publication
15.4.2018Registration
6.6.2031Expires

Marketing license

  • IS authorization number:
    EU/1/15/1043/001-002
  • Date:
    29.12.2015
  • Foreign authorization number:
    EU/1/15/1043
  • Date:
    2.12.2015

Owner

  • Name:
    GlaxoSmithKline LLC
  • Address:
    Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, DE US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents